Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Controlled Study of the Efficacy and Safety of Ingaron (Interferon-gamma Human Recombinant) in the Treatment of Chronic Prostatitis

NCT05378646 is registered in ClinicalTrials.gov with SPP Pharmaclon Ltd. as lead sponsor.

NCT NCT05378646
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05378646 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Controlled Study of the Efficacy and Safety of Ingaron (Interferon-gamma Human Recombinant) in the Treatment of Chronic Prostatitis
Lead sponsor
SPP Pharmaclon Ltd.
Phase
Phase 3
Overall status
Completed
Start date
January 29, 2009
Completion date
February 28, 2010
Enrollment
30 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic prostatitis